News

Related Biotechnology, Pharmaceutical and Healthcare News

MD Anderson Cancer Center, Pfizer Oncology partner to assess immuno-oncology combinations in blood cancers and solid tumors
Yale cancer researchers propose new ways to select patients for clinical trials
Pfizer, MD Anderson Cancer Center team up for immuno-oncology trials
MD Anderson, Pfizer Oncology to evaluate immuno-oncology combinations
Bristol-Myers Squibb Announces Expansion of the International Immuno-Oncology Network (II-ON) with Addition of Yale Cancer Center

Bristol-Myers Squibb Company announced that Yale Cancer Center has joined the International Immuno-Oncology Network (II-ON), a global peer-to-peer collaboration between Bristol-Myers Squibb and academia that aims to advance translational Immuno-Oncology (I-O) science.

Contributed Author:

BMS

Topics:

Industry News

BMS Announces Expansion of the International Immuno-Oncology Network with Addition of Yale Cancer Center

More From BioPortfolio on "BMS Announces Expansion of the International Immuno-Oncology Network with Addition of Yale Cancer Center"